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Objective: To determine whether mandibular condylar cartilage degradation induced by experimentally
abnormal occlusion could be ameliorated via systemic administration of strontium or NBD peptide.
Methods: Six-week-old female C57BL/6J mice were used. From the seventh day after mock operation or
unilateral anterior crossbite (UAC) treatment, the control and UAC mice were further respectively
pharmacologically treated for 2 weeks or 4 weeks of saline (CONþ Saline and UAC þ Saline groups), SrCl2
(CON þ SrCl2 and UAC þ SrCl2 groups) or NBD peptide (CON þ NBD peptide and UAC þ NBD peptide
groups). Changes in condylar cartilage and subchondral bone were assessed 21 and 35 days after mock
operation or UAC procedure by histology and micro-CT. Real-time PCR and/or immunohistochemistry
(IHC) were performed to evaluate changes in expression levels of col2a1, aggrecan, ADAMTS-5, tnf-a, il-
1b, nfkbia, nuclear factor-kappaB phospho-p65 in condylar cartilage, and rankl/rank/opg in both condylar
cartilage and subchondral bone.
Results: Cartilage degradation with decreased col2a1 and aggrecan expression, and increased ADAMTS-5,
tnf-a/il1-b, nfkbia and NF-kB phospho-p65 was observed in UAC þ Saline groups. Subchondral bone loss
with increased osteoclast numbers and decreased opg/rankl ratio was found in UAC þ Saline groups
compared to age-match CON þ Saline groups. Cartilage degradation and subchondral bone loss were
reversed by treatment of SrCl2 or NBD peptide while the same dosage in control mice induced few
changes in condylar cartilage and subchondral bone.
Conclusions: The results demonstrate reverse effect of systemic administration of strontium or NBD
peptide on UAC-induced condylar cartilage degradation and subchondral bone loss.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is histologically characterized by cartilage
degradation and abnormal subchondral bone remodeling1,2. It is
generally accepted that appropriate joint biomechanical loading is
essential for cartilage anabolic metabolism3, while abnormal jointM.-Q. Wang, State Key Labo-
natomy and Physiology and
al University, 145 Changlexi
ng).
ternational. Published by Elsevier Lloading results in cartilage metabolism imbalance favoring cata-
bolic metabolism and OA changes4e8. Abnormal joint loading could
downregulate expression of proteoglycans and Collagen II and
upregulate expression of inﬂammatory factors, such as interleukin-
1b (IL-1b) and tumor necrosis factor alpha (TNF-a), and cartilage
extracellular matrix degrading enzymes, such as a disintegrin and
metalloproteinase with thrombospondin motifs (ADAMTS) and
matrix metalloproteinases (MMPs)9. Several recent reports indicate
that nuclear factor-kappaB p65 (NF-kB p65) could directly bind to
the promoters of targeting genes encoding for cartilage degrading
factors10, such as ADAMTS-511, so NF-kB p65 is considered to play a
vital role as a pro-catabolic and pro-apoptotic factor of chondrocyte
during OA development12.td. All rights reserved.
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overlying articular cartilage. In the early stage of knee OA there was
a signiﬁcant decrease in bone volume fraction and changes in
subchondral bone architecture parameters, such as trabeculae
thickness and connectivity13, and increased levels of serum and
urinary bone remodeling markers, such as bone sialoprotein14, N-
terminal type I collagen telopeptides (NTx) and C-terminal type I
collagen telopeptides (CTX-1)15. In addition, low bone mineral
density and increased subchondral bone resorption were observed
in the early stage of OA animal models1,4,5,16. Inhibition of bone
resorption by pharmacologic inhibitors, such as bisphosphonates17,
strontium ranelate18,19 or OPG20 could effectively prevent surgically
induced-OA progression in rodents although contradictory results
were obtained from clinical studies aimed to prevent the cartilage
damage of knee OA by delivering bisphosphonates to OA patients16.
It seems that cartilage homeostasis andmetabolism ismechanically
and biochemically coupled with the subchondral bone16.
The bone remodeling process is initiated by bone resorption
coupled by the subsequent bone formation. Bone mass is lost when
the enhanced osteoclast activity surpasses the osteoblastic bone
formation. Using genetically-modiﬁed mouse models it has been
reported that the canonical and non-canonical NF-kB pathways
play important roles in promoting osteoclast differentiation and
maturation21. One of the NF-kB pathway activators is receptor
activator for nuclear factor-kappaB ligand (RANKL)/receptor acti-
vator for nuclear factor-kappaB (RANK) system. Although previous
studies have considered that RANKL in bone tissues mainly come
from the osteoblastic lineage cells22, recent studies from our group
and others have clearly shown that chondrocytes could also secret
RANKL which regulates postnatal bone remodeling through mod-
ulation of osteoclast formation4,23,24. One of the canonical NF-kB
pathway inhibitors is the cell-permeable NF-kB essential modu-
lator (NEMO) binding domain (NBD) peptide which could specif-
ically bind to the NEMO, the inhibitor of nuclear factor kappa-B
kinase subunit gamma (IKKg), and interfere with the formation of
IkB kinase (IKK) complex formation. Previous reports showed that
the NBD peptide could efﬁciently inhibit osteoclast formation, and
then decreased the pathological bone resorption in inﬂammatory
arthritis25,26. Recently, a clinically available drug, strontium rane-
late, has been proved to improve bone structures and to decrease
the risk of fracture of menopause osteoporotic patients27 and was
also reported to have both structure- and symptom-modifying
activity in patients with knee OA28. The possible mechanism is
that the strontium inhibits osteoclast maturation and promotes
osteoclast apoptosis, both of which have been reported to be
regulated by the NF-kB pathway29,30.
The temporomandibular joint (TMJ) is one of the most common
sites of OA31. We previously reported that the aberrant biome-
chanical loading resulting from disorder dental occlusion, termed
unilateral anterior crossbite (UAC), could induce obvious sub-
chondral bone loss and increased osteoclast activity in companion
with the cartilage degradation in mouse mandibular condyles6,8
while both the subchondral loss and cartilage degradation were
attenuated by reducing functional dietary loading8. Whether sys-
temic administration of NBD peptide or strontium could ameliorate
mandibular condyle cartilage degradation and subchondral bone
loss induced by UAC requires further investigation. In the present
study, the histomorphological and micro-CT analysis of mouse
mandibular condylar cartilage and/or subchondral bone was per-
formed. Real-time PCR and/or immunohistochemistry (IHC) were
carried out to evaluate the expression levels of cartilage catabolic
and anabolic factors including Collagen II and aggrecan, the
aggrecan degrading enzyme ADAMTS-5, the inﬂammation factors
tnf-a and il-1b, nfkbia (nuclear factor kappa-B inhibitor, alpha) and
NF-kB phospho-p65 in condylar cartilage. The mRNA expressionlevels of rank/rankl/osteoprotegerin (opg) in both condylar carti-
lage and subchondral bonewere also determined by Real-time PCR.
We hypothesized that systemic administration of NBD peptide or
strontium reverses the UAC-induced mandibular condylar cartilage
degradation and subchondral bone loss.
Material and methods
Mice and sample preparation
One hundred and eight 6-week-old C57BL/6J female mice
(weight about 16 g) were provided by the Animal Center of Fourth
Military Medical University. All procedures and animal care were
approved by the University Ethics Committee and performed ac-
cording to institutional guidelines. In the UAC groups, UAC was
applied to the mice as we previously described7,8. In the non-UAC
groups, mice underwent a mock operation procedure with no
abnormal biomechanical stimulation. At the seventh day after
mock operation or UAC treatment, the control and UAC mice were
further respectively pharmacologically treated for 2 weeks and 4
weeks as follows (n ¼ 9): intragastric administration of saline
(CON þ Saline and UAC þ Saline groups), intragastric administra-
tion of 4 mmol/kg SrCl2 (43966-5, SigmaeAldrich Co. LLC, USA) in
saline (CON þ SrCl2 and UAC þ SrCl2 groups) and i.p. injection of
5 mg/kg NBD peptide (IMG-2000-5, IMGENEX, USA) (CON þ NBD
peptide and UAC þ NBD peptide groups) and therefore three non-
UAC control groups (CON þ Saline, CON þ SrCl2 and CON þ NBD
peptide) and three UAC groups (UAC þ Saline, UAC þ SrCl2 and
UAC þ NBD peptide) were formed for the two time point. The
intraperitoneal injections were performed once every two days,
while the intragastric administrations were performed once per
day. All mice were sacriﬁced at the end of the third or ﬁfth week
after the mock operation or the installing procedure of UAC. No
mice showed any sign of disability, and they all received the same
standardized hard diet throughout the experiment8.
Because no differences in degrading changes were found be-
tween the left side and right side of the TMJs in the UACmice in our
previous report6, left side TMJ tissue blocks from six mice of each
group at the two time point were ﬁxed, decalciﬁed and embedded
in parafﬁn. The right side condyles from the six mice of each group
at the two time point (n ¼ 6) used for micro-CT scanning (Inveon,
Siemens, MUC, Bavaria, Germany) were separated from the
mandibular skulls4, and were immediately ﬁxed with 3% glutaral-
dehyde in 0.1 M sodium cacodylate buffer. For each group at the
two time point, the condylar cartilages and subchondral bones of
the 6 TMJs from 3 mice were respectively carefully separated and
preserved at 80C for RNA extraction. Condylar subchondral bone
3 mm beneath the cartilage-bone junctionwas cross-sectioned and
collected for RNA extraction as we reported6. Two condyles from a
mouse were pooled to create a single sample of the cartilage or
subchondral bone respectively for RNA extraction and 3 indepen-
dent samples were formed (n ¼ 3).
Micro-CT
The micro-CT scanning was reconstructed with an isotropic
voxel size of 10 mm and the three-dimensional images acquired
from microtomographic slices were utilized for quantitative eval-
uation. For subchondral bone histomorphometry, two cubes (each
0.25  0.25  0.25 mm) were selected at the middle of the center
and posterior of condylar subchondral bone. Within the selected
regions, bone volume fraction (BV/TV), trabecular thickness
(Tb.Th), trabecular number (Tb.N) and trabecular separation (Tb.Sp)
were measured by Health Care MicroView ABA 2.1.2 software as
described previously4,6,8.
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Fifteen central and para-central 5 mm thick sagittal sections
were prepared consecutively, and sections were randomly selected
for H&E staining, Safranin O staining, tartrate-resistant acid phos-
phatase (TRAP) staining and IHC staining of Collagen II, ADAMTS-5
and NF-kB phospho-p65 (Ser536). H&E and Safranin O staining was
used for histological assessment8, and TRAP staining was used for
the identiﬁcation of osteoclasts following the manufacturer's in-
structions (Sigma 387-A, St Louis, USA). Condyle cartilage thick-
ness, condylar cartilage cellular density, the percentages of
degraded cartilage areas, the Collagen II-positive areas and the
number of subchondral bone TRAP-positive osteoclasts were
measured as we reported previously4,6,8. Brieﬂy, the condylar
cartilage was evenly divided into anterior, central and posterior
thirds and the cartilage thickness in the central or posterior third
was measured and averaged. The condylar cartilage cellular density
and the percentages of degraded cartilage areas were calculated by
the value of the total cell number or the value of the total degraded
cartilage areas in the central and posterior thirds divided by the
value of the total area of the central and posterior thirds, respec-
tively. TRAP-positive osteoclasts were counted in ﬁve randomly
selected high-power (400) ﬁelds under a microscope (Leica DM
2500, Wetzlar, Germany) and the averaged value was used as the
value for this section8. All the measurements were carried out from
three sections per joint and the averaged value was used to
represent this joint for statistical analysis (n ¼ 6).
RNA extraction and real-time PCR
Total RNA was extracted by using Trizol (Invitrogen Life Tech-
nologies, CA, USA). The primers for target genes were listed in
Table I . Gene expressionwas analyzedwith the Applied Biosystems
7500 Real-time PCR machine (Applied Biosystems, CA, USA) with
GAPDH as the internal control. The results were calculated as the
relative quantiﬁcation compared to the 2-week CON þ Saline
group, which was set at 1. Data were collected from 3 independent
pooled samples (n ¼ 3).
Immunohistochemical staining
A standard, three-step, avidin-biotin complex IHC staining
protocol was carried out8. The primary antibodies were goat anti-
Collagen II (sc-7763, 1:50, Santa Cruz), rabbit anti-ADAMTS-5
(ab41037, 1:50, Abcam) and rabbit anti- NF-kB phospho-p65
(Ser536, ab131109, 1:50, Abcam). In negative control slides, non-
immune rabbit or goat serum was substituted for the primary
antibody5. The percentage of ADAMTS-5-positive or phospho-p65-
positive chondrocytes were calculated by the number of immune-
positive cell divided by total cell number from the six square
frames (each 0.08 mm  0.08 mm) in the center and posteriorTable I
Gene primers
Genes Forward primer
col2a1 CATCCAGGGCTCCAATGATGTA
aggrecan TTCCACCAGTGCGATGCAG
ADAMTS-5 AAGGGCACAGGCTACTATGTGG
tnf-a GACTAGCCAGGAGGGAGAACA
il-1b TCCAGGATGAGGACATGAGCAC
nfkbia GAAGCCGCTGACCATGGAA
rank GGCTTACCTGCCCAGTCTCATC
opg TTACCTGGAGATCGAATTCTGCT
rankl GCAGCATCGCTCTGTTCCTGTA
gapdh TGTGTCCGTCGTGGATCTGAcondylar cartilage thirds as reported previously8. The averaged
value of the percentages from three sections of each joint was
calculated to represent the sample for further statistical analysis
(n ¼ 3).
Statistical analysis
Data in the ﬁgures are expressed as means and 95% conﬁdence
intervals (CIs), and “n” represents the number of independent ob-
servations from different mice per group. Normality of data dis-
tributionwas tested by ShapiroeWilk test with 95% conﬁdence and
Levene's test was used to assess homogeneity of variance. The
percentages of degraded cartilage areas were compared by using
the non-parametric KruskaleWallis test and ManneWhitney U
test. For the other data, the assumptions of parametric tests were
fulﬁlled and two factors, group and time, were taken into consid-
eration when two-way ANOVA was applied for statistical analysis.
When signiﬁcant differences were found, Tukey test was used for
post hoc comparison between groups. SPSS 16.0 (SPSS Inc, IL, USA)
was used for the statistical analysis and P-values less than 0.05
were considered statistically signiﬁcant for all statistical tests.
Results
All mice are healthy and no signiﬁcant body weight changes
were noticed among the six groups at the two sampling times (The
body weights of the control and UAC mice were shown in
Supplemental Fig. 1).
Cartilage histomorphology and expression of proteoglycan, Collagen
II, aggrecan and ADAMTS-5
In the control groups of mandibular condylar cartilage, the
chondrocytes are distributed in zones. There is abundant extra-
cellular matrix proteoglycan and Collagen II in the hypertrophic
layer as revealed by H&E, Safranin O staining and Collagen II IHC
staining (Figs. 1 and 2 ). The CON þ Saline, CON þ SrCl2 and
CONþ NBD peptide groups showed no obvious histomorphological
differences. The cartilage thickness, condylar chondrocyte density
and the mRNA expressing levels of col2a1 and aggrecan by chon-
drocytes were similar among the three control groups both for 2-
week and 4-week time point (Figs. 1 and 2, P > 0.05).
In the UAC þ Saline groups, condylar cartilage degradation was
observed although the ﬁbrocartilage on the surface of the condylar
cartilage was intact [Figs. 1 and 2, (A)e(F)]. There were degraded
areas in the condylar cartilage with reduced cell number and the
loss of proteoglycan. The histological analysis demonstrated a
lower chondrocyte density, thinner mandibular condylar cartilage
thickness and decreased Collagen II-positive areas in 2-week and 4-
week UAC þ Saline groups compared to the age matched
CON þ Saline groups [all P < 0.001, Figs. 1 and 2, (A)e(B), (D)].Reverse primer
ATGTCCATGGGTGCGATGTC
TGGTGTCCCGGATTCCGTA
TC CAATAATGCCGTCACATCCAGTTC
GA CCTGGTTGGCTGCTTGCTT
GAACGTCACACACCAGCAGGTTA
GATCACAGCCAAGTGGAGTGGA
AAGCATCATTGACCCAATTCCAC
TG GTGCTTTCGATGAAGTCTCACCTG
CCTGCAGGAGTCAGGTAGTGTGTC
TTGCTGTTGAAGTCGCAGGAG
Fig. 1. Histomorphological observation on mandibular condyles from the control and UAC mice. Representative sections of Hematoxylin & Eosin (HE) staining, safranin O staining
and Collagen II IHC staining were shown. Bars ¼ 50 mm. CON þ Saline ¼ non-UAC (unilateral anterior cross-bite) control mice with 2-week or 4-week intragastric gavage of Saline;
CON þ SrCl2 ¼ the control mice with 2-week or 4-week intragastric gavage of SrCl2 (4 mg/Kg, 1 time/1d); CON þ NBD peptide ¼ the control mice with 2-week or 4-week
intraperitoneal injection of NBD peptide (5 mg/Kg, 1 time/2d); UAC þ Saline ¼ the UAC mice with 2-week or 4-week intragastric gavage of Saline; UAC þ SrCl2 ¼ the UAC mice
with 2-week or 4-week intragastric gavage of SrCl2 (4 mg/Kg, 1 time/1d); UAC þ NBD peptide ¼ the UAC mice with 2-week or 4-week intraperitoneal injection of NBD peptide
(5 mg/Kg, 1 time/2d). The mice were undergoing mock procedure or UAC treatment. From the seventh day after of a mock operation (control) or UAC treatment (UAC), the control
and UAC mice were further pharmacologically treated for 2 weeks (2w) or 4 weeks (4w) and sampled. The same group designations are also used in the other ﬁgures.
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col2a1 and aggrecan mRNA in UAC þ Saline groups were signiﬁ-
cantly decreased compared to the Con þ Saline groups and that the
expressions of ADAMTS-5 in mandibular condylar condylar carti-
lage from 2-week and 4-week UAC þ Saline groups were signiﬁ-
cantly elevated compared to the CON þ Saline groups [detailed P
values are shown in the legend, Fig. 2, (E)e(F) and Fig. 3 ].
It was further found in UAC þ SrCl2 and UAC þ NBD peptide
groups, the cartilage degradation was less severe than the
UAC þ Saline groups, as shown by increased cartilage thickness (all
P < 0.001) and cellular density (all P < 0.001), decreased percent-
ages of degraded cartilage areas [detailed P values are provided in
Fig. 2(C)], and larger Collagen II-positive areas [detailed P values are
shown in the legend, Fig. 2(D)]. The mandibular condylar cartilage
in UAC þ SrCl2 and UAC þ NBD peptide groups exhibited higher
mRNA expression levels of col2a1 and aggrecan, but lower
ADAMTS-5 level than the UACþ Saline groups [detailed P values are
shown in the legend, Fig. 2, (E)e(F) and Fig. 3]. Compared with 4-
week UAC þ SrCl2 group, the 4-week UAC þ NBD peptide group
showed relatively higher mRNA expression level of col2a1, and
lower mRNA expression level of ADAMTS-5 mRNA [detailed P
values are shown in the legend, Fig. 2, (E)e(F) and Fig. 3].Cartilage expression of tnf-a, il1-b, nfkbia and NF-kB phospho-p65
The mRNA expression levels of tnf-a/il1-b and nfkbia were
increased in the UAC þ Saline groups compared to their age-
matched CON þ Saline groups, whereas the 2 or 4 weeks treat-
ment of UAC mice by SrCl2 or NBD peptide decreased the expres-
sion levels of tnf-a/il1-b and nfkbia [Fig. 4(A)e(C) ], causing their
expression to return to the control levels [detailed P values are
shown in the legend, Fig. 4(A)e(C)]. The result of NF-kB phospho-
p65 IHC staining showed that percentages of phosphorylated NF-
kB p65-positive chondrocytes in the UAC þ Saline groups were
remarkably higher than those in the CON þ Saline groups (all
P < 0.001), while no such change was noticed in the age-matched
UAC þ SrCl2 and UAC þ NBD peptide groups [detailed P values
are shown in the legend, Fig. 4(D)e(E)].Subchondral bone histomorphometry
In controls, the 2-week or 4-week treatment of SrCl2 and NBD
groups displayed slightly but not signiﬁcantly higher BV/TV than
the CON þ Saline groups. There were no signiﬁcant subchondral
Fig. 2. Changes of mandibular condylar cartilage thickness (A), condylar cartilage cellular density (B), percentages of degraded cartilage areas (C), Collagen II-positive areas (D) and
cartilage mRNA expressing levels of col2a1 (E) and aggrecan (F) from the control and UAC mice. n ¼ 6 in (AeC) and n ¼ 3 in (DeF). For the percentages of degraded cartilage areas in
(C), every point represents the measurement outcome of an independent sample while the other data are expressed as means and 95% conﬁdence intervals (CIs) and * indicates
statistically signiﬁcant differences between groups. (A) P-values between groups with * are less than 0.001. (B) P-values between groups with * are less than 0.001. (D) P-values: 2w:
P-values between groups with * are less than 0.001; 4w: CON þ Saline vs UAC þ Saline, UAC þ SrCl2 and UAC þ NBD peptide: P < 0.001, P ¼ 0.003 and P ¼ 0.002; UAC þ Saline vs
UAC þ SrCl2 and UAC þ NBD peptide: P < 0.001 and P ¼ 0.001. (E) P-values: 2w: P-values between groups with * are less than 0.001; 4w: CON þ Saline vs CON þ NBD peptide,
UAC þ Saline and UAC þ SrCl2: all P < 0.001; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.011 and P < 0.001; UAC þ SrCl2 vs UAC þ NBD peptide: P ¼ 0.001. (F) P
values: 2w: non-UAC control (CON þ Saline) vs UAC þ Saline and UAC þ SrCl2: P < 0.001 and P ¼ 0.003; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.007 and
P < 0.001; UACþ SrCl2 vs UACþ NBD peptide: P ¼ 0.017; 4w: CONþ Saline vs UACþ Saline, UACþ SrCl2 and UACþ NBD peptide: P < 0.001, P < 0.001 and P ¼ 0.007; UAC þ Saline vs
UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.001 and P < 0.001.
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groups for the time points (Fig. 5 , P > 0.05).
In the UACþ Saline groups, largemarrowcavities were observed
from the histological and micro-CT images [Figs. 1 and 5(A)]. Bone
histomorphometric analysis revealed signiﬁcant reductions in BV/Fig. 3. Expression changes of ADAMTS-5 in mandibular condylar cartilage from the contro
UAC þ SrCl2 and UAC þ NBD peptide: P < 0.001, P < 0.001 and P ¼ 0.023; UAC þ Saline v
CON þ SrCl2, UAC þ Saline, UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.015, P < 0.001, P < 0.0
P < 0.001; UAC þ SrCl2 vs UAC þ NBD peptide: P ¼ 0.018. (B) Percentages of ADAMTS-5-posit
CONþ Saline vs UAC þ Saline and UAC þ SrCl2: P < 0.001 and P ¼ 0.008; UACþ Saline vs UAC
IHC staining of ADAMTS-5 in condylar cartilage from the 2-week and 4-week groups were
(CIs); * indicates statistically signiﬁcant differences between groups.TV and Tb.Th, and increases in Tb.Sp when compared to their age-
matched CON þ Saline mice [all P < 0.001, Fig. 5(B)e(D)]. However,
in UAC þ SrCl2 and UAC þ NBD peptide groups, there was an
attenuated subchondral bone loss to a similar extent, displaying as
higher values of BV/TV and Tb.Th, and lower values of Tb.Sp thanl and UAC mice. (A) ADAMTS-5 mRNA. P values: 2w: CON þ Saline vs UAC þ Saline,
s UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.03 and P < 0.001; 4w: CON þ Saline vs
01 and P < 0.001; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.001 and
ive chondrocyte. P values: 2w: P-values between groups with * are less than 0.001; 4w:
þ SrCl2 and UACþ NBD peptide: P ¼ 0.017 and P ¼ 0.018. (C) Representative sections of
shown. Bar ¼ 50 mm n ¼ 3; data are expressed as means and 95% conﬁdence intervals
Fig. 4. Expression changes of tnf-a, il-1b, nfkbia and NF-kB phospho-p65 (Ser536) in mandibular condylar cartilage from the control and UAC mice. (A) tnf-a mRNA. P values: 2w:
CON þ Saline vs UAC þ Saline and UAC þ SrCl2: P < 0.001 and P ¼ 0.017; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.03 and P ¼ 0.001; 4w: CON þ Saline vs
UAC þ Saline: P < 0.001; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.001 and P < 0.001. (B) il-1bmRNA. P values: 2w: P-values between groups with * are less than
0.001; 4w: CON þ Saline vs UAC þ Saline and UAC þ SrCl2: P < 0.001 and P ¼ 0.016; UAC þ Saline vs UACþ SrCl2 and UAC þ NBD peptide: both P < 0.001. (C) nfkbia mRNA. P values:
2w: CON þ Saline vs UAC þ Saline: P ¼ 0.003; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.009 and P ¼ 0.008; 4w: CON þ Saline vs UAC þ Saline: P < 0.001;
UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P < 0.001 and P ¼ 0.001. (D) Percentages of NF-kB phospho-p65 (Ser536)-positive chondrocyte were calculated from the
selected cartilage frames. P-values between groups with * are less than 0.001. (E) Representative sections of IHC staining of NF-kB phospho-p65 in condylar cartilage from the 2-
week and 4-week groups were shown, Bar ¼ 50 mm. n ¼ 3, data are expressed as means and 95% conﬁdence intervals (CIs); * indicates statistically signiﬁcant differences between
groups.
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shown in the legend, Fig. 1 and Fig. 5(A)e(D)]. The values of Tb.N
showed no difference among all the groups [Fig. 5(E)].
TRAP positive cells
In the mouse mandibular condyle subchondral bone, TRAP-
positive cell numbers were similar in the three control groups
[Fig. 6(A) and (B) , P > 0.05].
In the UACþ Saline groups, TRAP-positive cells was signiﬁcantly
increased compared to the age-matched control groups [both
P < 0.001, Fig. 6(A) and (B)]. In UAC þ SrCl2 and UAC þ NBD peptide
groups, however, the numbers of TRAP-positive cells were reduced
compared to their age-matched UAC þ Saline groups [detailed P
values are shown in the legend, Fig. 6(A) and (B)].
Expression of rank/rankl/opg
The rank mRNA levels in subchondral bone of 2-week and 4-
week UAC þ Saline groups were signiﬁcantly increased compared
to their age-matched control groups but in 2-week UACþ SrCl2 and
UAC þ NBD peptide groups, the rank mRNA levels were decreasedcompared to the 2-week UAC þ Saline group. In 4-week
CON þ SrCl2 and 4-week CON þ NBD peptide groups, the rank
mRNA levels were decreased to the 4-week CON þ Saline group
level [detailed P values are shown in the legend, Fig. 6(C)].
The mRNA expression levels of opg and rankl in cartilage
showed no differences in the three non-UAC control groups, while
the 4-week CONþ SrCl2 and CONþNBD peptide groups showed an
increased opg/rankl mRNA ratio in condylar subchondral bone as a
result of increased expression of opg in 4-week CON þ SrCl2 group
and slight decrease of rankl in 4-week CON þ NBD peptide group
compared to the 4-week CON þ Saline group [detailed P values are
shown in the legend, Fig. 7(A)e(F) ].
In the UAC þ Saline groups, mRNA levels of opg in cartilage or
subchondral bone were reduced while those of rankl expression
were signiﬁcantly or slightly increased, resulting in decreases of the
ratio of opg/rankl in both cartilage and subchondral bone compared
to their age-matched CON þ Saline groups [Fig. 7(A)e(F)]. In
UAC þ SrCl2 and UAC þ NBD peptide groups, however, there were
consistent increases in the opg mRNA expression and the ratio of
opg/rankl in both the mandibular condyle cartilage and sub-
chondral bone compared to their age-matched UAC þ Saline
groups, although the ratio of opg/rankl in cartilage of the
Fig. 5. Micro-CT images of the mandibular condylar head (A) and histomorphometry of mandibular condylar subchondral bone in the control and UAC mice. (B) Bone volume
fraction (BV/TV), (C) trabecular thickness (Tb.Th), (D) trabecular separation (Tb.Sp) and (E) trabecular number (Tb.N) were calculated from the selected subchondral cubes. n ¼ 6;
data are expressed as means and 95% conﬁdence intervals (CIs); * indicates statistically signiﬁcant differences between groups. Bars ¼ 200 mm. (B) P values: 2w: P-values between
groups with * are less than 0.001; 4w: CON þ Saline vs UAC þ Saline: P < 0.001; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.013 and P < 0.001. (C) P values: 2w:
CON þ Saline vs UAC þ Saline: P < 0.001; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.022 and P ¼ 0.011; 4w: CON þ Saline vs UAC þ Saline: P < 0.001; UAC þ Saline
vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.015 and P ¼ 0.006. (D) P values: 2w: CON þ Saline vs UAC þ Saline: P < 0.001; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide:
P ¼ 0.0012 and P ¼ 0.001; 4w: CON þ Saline vs UAC þ Saline: P ¼ 0.027; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.045 and P ¼ 0.012.
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those of the age-matched non-UAC CONþ Saline groups [detailed P
values are shown in the legend, Fig. 7(A)e(F)].
Discussion
The current data demonstrate that systemic administration of
either strontium or NBD peptide reverses not only the subchondral
bone loss but also the mandibular condylar cartilage degradation
induced by UAC as evidenced by increased cartilage thickness and
cell density, increased expression of cartilage matrix molecules
such as Collagen II and aggrecan, and decreased expression of
cartilage catabolic factors, such as ADAMTS-5, il-1b and tnf-a. In
contrast, systemic administration of either strontium or NBD pep-
tide induces no signiﬁcant changes in non-UAC control condylar
cartilage, and slightly increases the values of BV/TV and opg/rankl
mRNA ratio in the subchondral bone. These ﬁndings are supported
by the recent ﬁnding that abnormal remodeling of subchondral
bone caused by activation of TGF-b signaling leads to OA-like
pathological changes in cartilage of both knee and TMJs32,33, and
inhibition of the TGF-b signaling could largely attenuate cartilage
degeneration32. What deserves to be mentioned is that there were
indeed profound cell losses in the ﬁbrous layer, as well as in the
proliferative layer of the articular cartilage in UAC groups. However
the surfaces of the condylar cartilagewere intact. This phenomenon
was noticed in all of our previous reports using the same meth-
ods6e8. It seems different from knee joint17. Based on our ﬁndings in
this report and previous reports6e8, the observed degenerativealterations are unique to mandibular condyles and are quite
different from those displayed in other joints. The ﬁbrous layer is
much thicker in TMJ condylar cartilage than that in knee cartilage,
which might be a contribution to the phenomenon, yet needs a
future clariﬁcation.
The subchondral bone provides the mechanical support for the
overlying articular cartilage and undergoes constant modeling or
remodeling in response to changes of the joint loading. Loss of
subchondral bonewill trigger degradation of the overlying cartilage
through aggravating their biomechanical environment16,34e36. The
improved subchondral bone architectures via systemic adminis-
tration of strontium and NBD peptide may then take a role in
protecting cartilage from degradation considering the biome-
chanical effect of subchondral bone on the overlied cartilage as
Radin et al.34 proposed. Further, NF-kB signal has been shown to
have multiple effects on chondrocytes metabolism, promoting the
expression of pro-inﬂammatory cytokines, such as il-1b and tnf-a
and matrix degrading enzymes, such as ADAMTS-510e12. Intra-
articular injection of adenoviral vector-expressing NF-kB p65-
speciﬁc shRNA to inhibit the NF-kB signal has been shown to alle-
viate cartilage degradation and synovium inﬂammation in the rat
experimental knee OA model37. There is a possibility that the sys-
temically delivered drugs may pass through the osteochondral
junction and act directly on articular cartilage via osteochondral
vascular tissues as it was suggested38, because the tide mark or
boundary between cartilage and bone in TMJs of young mice like
the currently used is not obvious as displayed in our results. That
means the strontium or NBD peptide may be able to penetrate into
Fig. 6. The osteoclast numbers in the mandibular condylar subchondral bone in the control and UAC mice. (A) TRAP staining in the mouse mandibular condylar subchondral bone.
Bars¼ 200 mm in the low-magniﬁcation images and Bars¼ 50 mm in the high-magniﬁcation images. (B)Quantitative analysis of TRAP-positive osteoclasts (n¼ 6). P values: 2w: P-values
betweengroupswith * are less than0.001; 4w: CONþ Saline vsUACþ Saline andUACþ SrCl2: P<0.001 and P¼ 0.032;UACþ Saline vsUACþ SrCl2 andUACþNBDpeptide: both P<0.001.
(C)mRNAexpressing levels of rank in condylar subchondral bonewere shown (n¼ 3). P values: 2w:CONþ Saline vsUACþ Saline, UACþ SrCl2 andUACþNBDpeptide: P<0.001, P¼ 0.005
and P¼ 0.015; UACþ Saline vs UACþ SrCl2 and UACþNBD peptide: P¼ 0.002 and P¼ 0.001; 4w: CONþ Saline vs UACþ Saline: P¼ 0.001; UACþ Saline vs UACþ SrCl2 and UACþ NBD
peptide: P ¼ 0.002 and P < 0.001. Data are expressed as means and 95% conﬁdence intervals (CIs); * indicates statistically signiﬁcant differences between groups.
Fig. 7. Expression of opg and rankl in mandibular condylar cartilage and subchondral bone of the control and UAC mice (n ¼ 3). Data are expressed as means and 95% conﬁdence
intervals (CIs); * indicates statistically signiﬁcant differences between groups. (A) P values: 2w: CON þ Saline vs UAC þ Saline: P ¼ 0.001; UAC þ Saline vs UAC þ SrCl2 and
UAC þ NBD peptide: P ¼ 0.006 and P ¼ 0.021; 4w: P-values between groups with * are less than 0.001. (B) P values: 2w: CON þ Saline vs UAC þ Saline: P ¼ 0.003; UAC þ Saline vs
UAC þ NBD peptide: P ¼ 0.022. (C) P-values between groups with * are less than 0.001. (D) P values: 2w: UAC þ Saline vs CON þ Saline, UAC þ SrCl2 and UAC þ NBD peptide:
P < 0.001, P ¼ 0.001 and P ¼ 0.001; 4w: UAC þ Saline vs CON þ Saline and UAC þ NBD peptide: P ¼ 0.001 and P ¼ 0.001; CON þ Saline vs CON þ SrCl2: P ¼ 0.047. (E) P values: 2w:
CON þ Saline vs UAC þ Saline, UAC þ SrCl2 and UAC þ NBD peptide: P < 0.001, P ¼ 0.001 and P ¼ 0.010; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: P ¼ 0.003 and
P < 0.001; 4w: CON þ Saline vs UAC þ Saline, UAC þ SrCl2 and UAC þ NBD peptide: P < 0.001, P ¼ 0.004 and P < 0.010; UAC þ Saline vs UAC þ SrCl2: P < 0.001. (F) P values: 2w: P-
values between groups with * are less than 0.001; 4w: CON þ Saline vs CON þ SrCl2, CON þ NBD peptide, UAC þ Saline, UAC þ SrCl2 and UAC þ NBD peptide: P < 0.001, P ¼ 0.023,
P < 0.001, P < 0.001 and P < 0.010; UAC þ Saline vs UAC þ SrCl2 and UAC þ NBD peptide: both P < 0.001.
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NF-kB signal evoked by the abnormal loading in UAC mice. Further
studies on the mechanism of strontium or NBD peptide on articular
cartilage and subchondral bone will help us elucidate the direct
effect of strontium on NF-kB signal under normal or OA situation.
Previous studies have revealed that targeting subchondral bone
with the agents regulating bone remodeling, such as bisphospho-
nates, estrogens, calcitonin, OPG and PTH (1e34)16e20 has protec-
tive effects on both subchondral bone and articular cartilage in OA.
Strontium has been proposed as an anti-osteoporotic drug capable
of rebalancing bone turnover, improving bone morphology, pre-
serving bone matrix mineralization, and restoring bone biome-
chanical properties in in vitro and in vivo studies and clinical
studies39e41. The current results demonstrate that oral SrCl2 treat-
ment at 4 mmol/kg/d was able to effectively preserve the normal
properties of subchondral bone in mandibular condyles of UAC
mouse, as demonstrated by the improvement in morphology,
microarchitecture indices, osteoclast number and opg/rankl ratio.
Although the mechanisms by which the strontium exerts its effects
remains relatively unclear, the ﬁndings of present studies implied
that SrCl2 exerts its effects by mediating RANKL/RANK/OPG
pathway because treatment with SrCl2 inhibits expression of rankl
in subchondral bone of UACmice, but stimulates their expression of
opg, hence increased opg/rankl ratio in mandibular condyle sub-
chondral bone, a result that is in line with previous study showing
that SrCl2 could up-regulate OPG expression and increase opg/rankl
ratio in osteoblasts41, and inhibit osteoclast activity29, and that the
NBD peptide could effectively inhibit the increased NF kappaB
signaling in active osteoclasts but spare the normal NF kappaB
signaling during osteoclast activity25.
In conclusion, the present studies indicate a rescue effect of the
systemic administration of strontium or NBD peptide on the sub-
chondral bone loss and cartilage degeneration in the early stage OA
induced by UAC. This would be of clinical signiﬁcance considering
that a pharmacological administration of strontium or NBD peptide
might be helpful to promote mandibular condyle recovering from
degradation caused by abnormal occlusions.
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